
Organometallics p. 2262 - 2275 (1990)
Update date:2022-07-31
Topics:
Schrock
DePue
Feldman
Yap
Yang
Davis
Park
DiMare
Schofield
Anhaus
Walborsky
Evitt
Krüger
Betz
An alternative synthesis of W(CH-t-Bu)(NAr)(dme)Cl2 (Ar = 2,6-C6-H3-i-Pr2) consists of the five steps WCl6 → W(O)Cl4 → W(NAr)Cl4 → W(NAr)(O-t-Bu)2Cl2(THF) → W(NAr)(O-t-Bu)2(CH2-t-Bu)2 → W-(CH-t-Bu)(NAr)(dme)Cl2, in which tert-butoxide "protecting groups" are replaced by chlorides in the last step upon addition of PCl5. The easiest synthesis to a catalyst precursor consists of the three steps WO2Cl2 → W(NAr)2Cl2(dme) → W(NAr)2(CH2R)2 → W(CHR)(NAr)(OTf)2(dme) (R = t-Bu, CMe2Ph; OTf = OSO2CF3), in which an imido ligand protecting group is ultimately replaced by two triflate ligands upon addition of triflic acid in the last step. An X-ray study of W(CH-t-Bu)(NAr)(O-t-Bu)2 shows it to be a pseudotetrahedral complex in which the tert-butyl group points toward the imido ligand (syn conformation; space group P1, a = 14.050 (5) ?, b = 18.885 (5) ?, c = 11.123 (5) ?, α = 92.22 (3)°, β = 108.30 (3)°, γ = 79.25 (2)°, V = 2752 (2) ?3, Z = 4, Mr 572.46, ρ = 1.381 g cm-3, μ = 43.03 cm-1; R = 0.039, Rw = 0.043). Complexes of the type W(CH-t-Bu)(NAr′)(OR)2 (NAr′ = N-2,6-C6H3Me2; OR = O-t-Bu, OCMe2(CF3), OCMe(CF3)2, OC(CF3)2(CF2CF2CF3)) were prepared by methods analogous to those used originally to prepare NAr complexes. Reactions between NAr′ complexes and olefins in general yield less stable organometallic products than when the NAr ligand is present. In one case (addition of internal olefins to W(CH-t-Bu)(NAr′)[OCMe(CF3)2]2) a product was isolated that was consistent with the formation {W(NAr′)-[OCMe(CF3)2]2}2. Some of the W(CH-t-Bu)(NAr)X2 variations that were prepared include X = OAr, OCEt3, OCMe2Ph, SAr, and CH2-t-Bu. Other variations include W(CHEt)(NAr)X2 complexes (X = OCEt3, NPh2), W(CHSiMe3)(NAr)X2 complexes (X = OAr, OCMe2(CF3), OCMe(CF3)2), and W[CHSi(OMe)3](NAr)X2 complexes (X = OAr, OCMe2(CF3), OCMe(CF3)2). Syn and anti rotamers of W(CHSiMe3)(NAr)(OAr)2 were observed and found to interconvert on the NMR time scale (ΔG?298 = 15.0 (1) kcal mol-1). None of the variations have any obvious advantage over known alkoxide/NAr complexes for metathesis of ordinary or strained cyclic olefins. An attempt to prepare a derivative containing the OC(CF3)2(tolyl) ligand yielded W[OC(C6H3Me)(CF3)2](NAr)[OC(CF 3)2(tolyl)](CH2-t-Bu), formed by addition of an ortho CH bond to the W=C bond (space group P21/c, a = 16.821 (2) ?, b = 11.951 (1) ?, c = 19.455 (4) ?, β = 93.852 (8)°, V = 3920.5 ?3, Z = 4, Mr 943.6, ρ(calcd) = 1.606 g cm-3, μ = 31.09 cm-1; R = 0.038, Rw = 0.043).
View MoreContact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Shanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Contact:
Address:308# dongwu avenue dongxihu district wuhan city
Doi:10.1016/j.tet.2004.06.005
(2004)Doi:10.1002/asia.201800603
(2018)Doi:10.1134/S1070363208090120
(2008)Doi:10.1016/S0040-4020(01)82117-7
(1966)Doi:10.1021/ja00196a003
(1989)Doi:10.1093/oxfordjournals.rpd.a033158
(1957)